Cabio Biotech (Wuhan) Co (SHSE:688089) Change In Inventory : ¥0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cabio Biotech (Wuhan) Co Change In Inventory?

Cabio Biotech (Wuhan) Co's change in inventory for the quarter that ended in Dec. 2024 was ¥0.0 Mil. It means Cabio Biotech (Wuhan) Co's inventory stayed the same from Sep. 2024 to Dec. 2024 .

Cabio Biotech (Wuhan) Co's change in inventory for the fiscal year that ended in Dec. 2024 was ¥-39.9 Mil. It means Cabio Biotech (Wuhan) Co's inventory increased by ¥39.9 Mil from Dec. 2023 to Dec. 2024 .

Cabio Biotech (Wuhan) Co's Total Inventories for the quarter that ended in Dec. 2024 was ¥139.3 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Cabio Biotech (Wuhan) Co's Days Inventory for the quarter that ended in Dec. 2024 was 154.01.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cabio Biotech (Wuhan) Co's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.59.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cabio Biotech (Wuhan) Co's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.80.

Cabio Biotech (Wuhan) Co Change In Inventory Historical Data

The historical data trend for Cabio Biotech (Wuhan) Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cabio Biotech (Wuhan) Co Change In Inventory Chart

Cabio Biotech (Wuhan) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

2.58

-4.87

-9.22

-39.59

-39.94

Cabio Biotech (Wuhan) Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Cabio Biotech (Wuhan) Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Cabio Biotech (Wuhan) Co (SHSE:688089) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cabio Biotech (Wuhan) Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	135.263	/	80.145	*	365 / 4
	=	154.01

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cabio Biotech (Wuhan) Co's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	80.145	/	135.263
	=	0.59

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cabio Biotech (Wuhan) Co's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	135.263	/	168.445
	=	0.80

Cabio Biotech (Wuhan) Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Cabio Biotech (Wuhan) Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cabio Biotech (Wuhan) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 999, Gaoxin Avenue, East Lake New Technology Development Zone, Hubei Province, Wuhan, CHN, 430075

Website

http://www.cabio.cn

Cabio Biotech (Wuhan) Co Ltd is a biotechnology company, engaged in Research & Development, production and sales of polyunsaturated fatty acids ARA, algae oil DHA and SA, natural B-carotene and other series products. The products are used in infant formula, dietary nutrition supplements and health Food, special medical formula food and other fields. The company's product sales area covers China, the United States, Europe, Australia, New Zealand, South Korea, and Southeast Asia.

Executives

Shang Yun	Core technical personnel
Xiao Min	senior management
Wang Hua Biao	Directors, senior managers
Geng An Feng	senior management
Du Bin	Director
Yi Hua Rong	senior management
Ma Tao	senior management
Li Xiang Yu	senior management
Wu Yu Jun	Supervisors
Wang Zhi Ming	senior management
Lu Shu Huan	Core technical personnel
Yi De Wei	Director

Cabio Biotech (Wuhan) Co Headlines

No Headlines